KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Liabilities and Shareholders Equity (2016 - 2025)

Biogen (BIIB) has 17 years of Liabilities and Shareholders Equity data on record, last reported at $29.4 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 4.96% year-over-year to $29.4 billion; the TTM value through Dec 2025 reached $115.0 billion, up 4.81%, while the annual FY2025 figure was $29.4 billion, 4.96% up from the prior year.
  • Liabilities and Shareholders Equity reached $29.4 billion in Q4 2025 per BIIB's latest filing, up from $29.2 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $29.4 billion in Q4 2025 and bottomed at $23.6 billion in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $26.2 billion, with a median of $25.9 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: fell 8.67% in 2021, then increased 13.43% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $23.9 billion in 2021, then rose by 2.83% to $24.6 billion in 2022, then rose by 9.33% to $26.8 billion in 2023, then rose by 4.49% to $28.0 billion in 2024, then rose by 4.96% to $29.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $29.4 billion in Q4 2025, $29.2 billion in Q3 2025, and $28.3 billion in Q2 2025.